Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingEARLY_PHASE1

Conditions

Duchenne Muscular Dystrophy (DMD)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, Shanghai Municipality, China
Contact: Study coordinator (Jiwen Wang) · wangjiwen@scmc.com.cn · +86 189 1661 3192
Contact: Principal Investigator (Jiwen Wang)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in Duchenne Cardiomyopathy

Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingPHASE1

Nashville, United States

A Study to Investigate the Safety and Biodistribution of a Single Intrathecal (IT) Injection of INS1201 in Ambulatory Males With Duchenne Muscular Dystrophy (DMD)

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE1

Little Rock, United States · Davis, United States

Safety and Dystrophin Expression of SPOT-03 in Duchenne Muscular Dystrophy (DMD) Patients

Duchenne Muscular Dystrophy (DMD)

Abroad (travel likely)RecruitingEARLY_PHASE1

Shanghai, China

Trial of Cell Based Therapy for DMD

Duchenne Muscular Dystrophy

Abroad (travel likely)RecruitingPHASE1

Minneapolis, United States